Skip to content

Prospective Self-Controlled Open Clinical Trial of Human NegativePressure Chamber on Clearing Senescent Cells

Prospective self-controlled open clinical trial of human hypobaric pressure chamber on clearing senescent cells

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123252
Enrollment
Unknown
Registered
2026-04-23
Start date
2026-04-24
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Interventions

Control group:Subjects sat in a negative pressure chamber for one hour twice a week, with the negative pressure set at normal atmospheric pressure: 90 kPa. The total treatment course included 8 interv
Experimental group:Subjects sat in a negative pressure chamber for one hour twice a week, with the negative pressure set at normal atmospheric pressure: 50 kPa. The total treatment course included 8 i

Sponsors

Sun Yat-sen University Affiliated Stomatological Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Subjects >=40 years old, male or female; 2. No cognitive impairment; 3. The subjects have no severe hypertension, cardiovascular and cerebrovascular diseases, ear diseases or hearing disorders, and no large wounds or exposed wounds; 4. 18.5kg/m^2 =50kg, female weight >=45kg; 5. No treatment related to chemoradiation, immunosuppressive drugs or flavonoids were used; 6. The subjects fully understand the purpose and requirements of the trial, voluntarily participate in the clinical trial and sign a written informed consent, and are willing to complete the entire trial process according to the requirements of the trial.

Exclusion criteria

Exclusion criteria: 1. People with obvious mental disorders; 2. Claustrophobic subjects; 3. High myopia (>=1000 degrees), severe glaucoma, cataract, severe ear disease or hearing impairment; 4. Serious heart, lung, liver, kidney dysfunction; 5. Patients with a history of epilepsy (excluding febrile convulsions in children); 6. Pregnant and lactating women; 7. Subjects that the researcher considers inappropriate to participate in this experiment; 8. Other subjects who are not suitable for negative pressure therapy.

Design outcomes

Primary

MeasureTime frame
Complete Blood Count Type;Liver and kidney function tests;Coagulation function;Blood lipid level;Number of senescent cells in the blood;Serum inflammatory factor levels;Age-related genes and proteins;

Secondary

MeasureTime frame
Mitochondrial function;Bodily functions;Skin aging;Metabolic and immune functions;

Countries

China

Contacts

Public ContactXueli Mao

Sun Yat-sen University Affiliated Stomatological Hospital

maoxuel@mail.sysu.edu.cn+86 139 0240 1449

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026